← Back to Home

How Does Cancer-Associated Protein ETV4 Awaken Silent DNA? Fruit Fly Experiments Identify an Essential Partner

How does a stretch of previously silent repetitive DNA become a switch that regulates genes? Research indicates that ETV4 needs help from another class of proteins to initiate this process, offering clues to understanding abnormal gene regulation in some cancers.

By SURL BioNews

Abnormalities in cancer cells sometimes arise when previously silent DNA is reactivated. Using fruit flies, scientists found that the cancer-associated human protein ETV4 needs another protein partner to enable a class of repetitive DNA sequences to begin regulating genes. The findings add a piece to the mechanistic puzzle of how cancer rewrites the way genes work.

The research was conducted by Cayetano González’s team at the Institute for Research in Biomedicine Barcelona (IRB Barcelona), in collaboration with Jaume Mora and colleagues at the Sant Joan de Déu Hospital’s Barcelona Children’s Cancer Center. The paper was published on September 22 in *G3: Genes|Genomes|Genetics*, and the research institution announced the findings on October 13. Coverage of the same findings published by Medical Xpress the following day was also provided by IRB Barcelona.

The research focuses on “GGAA microsatellites”: short sequences consisting of repeated arrangements of the four DNA letters GGAA. In Ewing sarcoma, the fusion of portions of proteins from the FET and ETS families can turn these silent sequences into enhancers that promote gene expression. Previous studies have shown that certain ETS proteins in prostate cancer and B-cell acute lymphoblastic leukemia can also activate related sequences even without this type of protein fusion; how this works remains to be clarified.

Fruit flies provide a system that is easier to dissect. Humans have three closely related FET-family proteins—FUS, EWSR1, and TAF15—that may compensate for one another, making their individual functions difficult to distinguish. Fruit flies have only one corresponding protein, Cabeza, abbreviated as Caz. After introducing human ETV4 into fruit flies, the team observed activation of a GGAA fluorescent reporter system in specific glandular tissues.

The key evidence came from experiments that reduced Caz: activation induced by ETV4 weakened markedly, and activity could be restored by adding human EWSR1. By contrast, the Ewing sarcoma-associated fusion protein EWS::FLI1 could activate the sequences without relying on the fruit flies’ own Caz. This comparison supports an explanation: unfused ETV4 needs assistance from a separate FET protein, whereas the fusion protein already joins the two types of functions together.

The team also found that the human transcriptional repressor ETV6 could suppress ETV4 activity in fruit flies. However, ETV4’s effects varied by tissue and were not observed in all tissues tested, indicating that the cellular environment also influences whether these DNA switches can function.

This study establishes mechanistic evidence in living fruit flies, primarily by observing transcriptional activity through artificially designed repetitive sequences and reporter systems. It has not demonstrated that blocking this cooperation can treat human cancer, and its findings cannot be directly applied to all related tumors. The next step still requires confirming, within the native genomic context of human tumor cells, which sequences and genes depend on this mechanism and what effects intervention would have.

References

  1. IRB Barcelona
  2. Medical Xpress